Yuqing Gong

harbin university of science & technology

H指数:15

被引数:1,055

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Single-Cell Sequencing Analysis-Driven Nanomedicine Design for Mimicking Endogenous Immune Repair in Myocardial Infarction

单细胞测序分析驱动的纳米医学设计：模拟心肌梗死中内源性免疫修复

ACS Nano

IF16

2026-04-040

PRE

Systematic Identification and Functional Insights into IGT Family Members Involved in Leaf Angle Regulation and Abiotic Stress Response in Sugarcane

系统鉴定及功能解析参与甘蔗叶角调控和非生物胁迫响应的IGT家族成员

Plant Physiology and Biochemistry

IF5.7

2026-03-200

PREAI

Genome-wide analysis of the sugarcane SUT gene family reveals ShSUT4 as a key regulator of abiotic stress responses

甘蔗SUT基因家族的全基因组分析揭示了ShSUT4是调控非生物胁迫响应的关键因子

Theoretical and Applied Genetics

IF4.2

2026-01-050

PRE

A dimension-reduced sliding mode control approach for fuzzy parameter-varying systems

一种降维滑模控制方法用于模糊参数变化系统

Transactions of the Institute of Measurement and Control

IF1.9

2026-01-010

PRE

Microcystin-LR Triggers Renal Tubular Ferroptosis Through Epigenetic Repression of GPX4: Implications for Environmental Nephrotoxicity

微囊藻毒素-LR通过表观遗传抑制GPX4触发肾小管铁死亡：对环境肾毒性的意义

ADVANCED SCIENCE

IF14.1

2025-11-010

OAAI

Nomogram model to predict in-hospital mortality in lung transplant recipients: A retrospective cohort study

预测肺移植受者院内死亡风险的列线图模型：一项回顾性队列研究

RESPIRATORY MEDICINE

IF3.1

2025-09-010

PRE

IR780-Loaded E. coli Membrane Nanovesicles Combined with Photodynamic Therapy to Enhance Immunogenicity in Osteosarcoma

IR780负载的E. coli膜纳米囊泡与光动力疗法联合应用以增强骨肉瘤的免疫原性

ACS Applied Nano Materials

IF5.5

2025-07-220

PRE

MiR-21-5p-enriched exosomes from hiPSC-derived cardiomyocytes exhibit superior cardiac repair efficacy compared to hiPSC-derived exosomes in a murine MI model

在小鼠MI模型中，与hiPSC衍生的外泌体相比，来自hiPSC衍生的心肌细胞的MiR-21-5p-enriched外泌体表现出更好的心脏修复功效

WORLD JOURNAL OF STEM CELLS

IF3.6

2025-03-260

PRE

Leveraging Model Master Files for Long-Acting Injectables (Jan, 10.1007/s11095-025-03824-4, 2025)

PHARMACEUTICAL RESEARCH

IF4.3

2025-02-120

OAAI

Leveraging Model Master Files for Long-Acting Injectables

PHARMACEUTICAL RESEARCH

IF4.3

2025-01-281

OAAI

A 2024 Update on US FDA Implementation of Partial Area Under the Curve Into Bioavailability and Bioequivalence Assessments

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2025-01-180

PRE

Exploration of the potential impact of batch-to-batch variability on the establishment of pharmacokinetic bioequivalence for inhalation powder drug products

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2024-11-220

OAAI

Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability

AAPS JOURNAL

IF3.7

2024-04-261

PRE

Application of Advanced Modeling Approaches Supporting Generic Product Development Under GDUFA for Fiscal Year 2023

AAPS JOURNAL

IF3.7

2024-04-240

Leveraging Modeling and Simulation to Enhance the Efficiency of Bioequivalence Approaches for Generic Drugs: Highlights from the 2023 Generic Drug Science and Research Initiatives Public Workshop

利用建模和仿真提高仿制药生物等效性方法的效率: 2023仿制药科学和研究计划公共研讨会的亮点

AAPS JOURNAL

IF3.7

2024-04-082

PRE

The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA

AAPS JOURNAL

IF3.7

2024-02-278

PRE

Development of Quantitative Comparative Approaches to Support Complex Generic Drug Development

AAPS JOURNAL

IF3.7

2024-01-241

PRE

FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth

CELL REPORTS

IF6.9

2023-08-015

Establishing the suitability of model-integrated evidence to demonstrate bioequivalence for long-acting injectable and implantable drug products: Summary of workshop

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2023-02-099

OAAI

Usage of Compartmental Models in Predicting COVID-19 Outbreaks

AAPS JOURNAL

IF3.7

2022-09-0214

OAAI

Yuqing Gong

个人简介

教育背景

工作经历

荣誉奖项

研究方向